NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00003912,Chemotherapy in Treating Children With Liver Cancer,https://clinicaltrials.gov/study/NCT00003912,,COMPLETED,"RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which chemotherapy regimen is more effective in treating children with liver cancer.

PURPOSE: Randomized phase III trial to study the effectiveness of cisplatin with or without doxorubicin and the effectiveness of combining cisplatin, carboplatin, and doxorubicin in treating children who have liver cancer.",NO,Liver Cancer,DRUG: carboplatin|DRUG: cisplatin|DRUG: doxorubicin hydrochloride|PROCEDURE: conventional surgery,Tumor response|Complete resection rate|Overall survival|Event-free survival|Toxicity|Response rate|Resection rate,,,Societe Internationale d'Oncologie Pediatrique,,ALL,CHILD,PHASE3,260,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,CDR0000067091|SIOP-SIOPEL-3|EU-98067|UKCCSG-LT-1998-01,1998-06,,2009-10,2003-01-27,,2013-12-04,"Azienda Ospedaliera di Padova, Padova, 35128, Italy",
